A Phase 1/2a First-in-Human, Dose-Escalation Study to Evaluate TRX319 in Subjects with Progressive Multiple Sclerosis
Grant Award Details
Grant Type:
Grant Number:
CLIN2-19848
Investigator(s):
Award Value:
$8,000,000
Status:
Pre-Active
Grant Application Details
Application Title: